Skip to main content

Volume 15 Supplement 3

Sepsis 2011

Efficacy of endotoxin absorption therapy on sepsis by polymyxin B-attached fibers


Endotoxin plays a role in the development of Gram-negative bacterial sepsis. In Japan, polymyxin B-attached fibers (PMX-B) are used clinically as an endotoxin absorption therapy to neutralize the biological activity of lipid A, the immunomodulatory center of lipopolysaccharide (LPS) endotoxin. Because hemodynamic improvement is not seen in all cases, it cannot be assumed that this therapy will be effective against all cases of sepsis.


Endotoxin absorption therapy is effective against abdominal infection. Moreover, the mortality rate significantly improved in endotoxin-positive cases of abdominal infection.


Between 1997 and April 2008, endotoxin absorption therapy was performed on 105 septic patients in the ICU of Hyogo College of Medicine and the Osaka City General Hospital. The 105 cases were divided into an abdominal infection group (n = 45) and a nonabdominal infection group (n = 60). Before and after therapy, the endotoxin level was measured in patients using the limulus amoebocyte lysate (LAL) and endotoxin activity assay (EAA) methods. Moreover, we measured blood pressure, cardiac index, and the administered dose of catecholamine. Using a retrospective analysis, we compared Sequential Organ Failure Assessment (SOFA) scores; the Risk, Injury, Failure, Loss, and End stage (RIFLE) criteria; and the 28-day survival rate between the two groups.


After the endotoxin absorption therapy, mean blood pressure increased significantly from 67.9 ± 11.4 to 86.4 ± 6.3 mmHg in the abdominal infection group, whereas there was no change in the nonabdominal infection group. After the therapy, the SOFA scores and RIFLE criteria improved in both groups, but they improved significantly in the abdominal infection group. Patients in the abdominal infection group, especially the endotoxin-positive cases, recovered earlier from shock and had a significantly higher rate of survival than the abdominal infection group.


In endotoxin-positive patients with an abdominal infection, absorption therapy improved survival rate and cardiac and renal dysfunction due to sepsis or septic shock. However, further studies are required to verify the effectiveness of endotoxin absorption therapy.

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Atagi, K. Efficacy of endotoxin absorption therapy on sepsis by polymyxin B-attached fibers. Crit Care 15 (Suppl 3), P42 (2011).

Download citation

  • Published:

  • DOI: